ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Role of DNA Methylation in Renal Cell Carcinoma.

Lasseigne Brittany N*; Brooks James DStanford University medical center
Molecular Diagnosis and Therapy2018-5-18DOI: 10.1007/s40291-018-0337-9
6阅读
引用收藏
分享

摘要

Renal cell carcinoma (RCC) is the most common kidney cancer and includes several molecular and histological subtypes with different clinical characteristics. While survival rates are high if RCC is diagnosed when still confined to the kidney and treated definitively, there are no specific diagnostic screening tests available and symptoms are rare in early stages of the disease. Management of advanced RCC has changed significantly with the advent of targeted therapies, yet survival is usually increased by months due to acquired resistance to these therapies. DNA methylation, the covalent addition of a methyl group to a cytosine, is essential for normal development and transcriptional regulation, but becomes altered commonly in cancer. These alterations result in broad transcriptional changes, including in tumor suppressor genes. Because DNA methylation is one of the earliest molecular changes in cancer and is both widespread and stable, its role in cancer biology, including RCC, has been extensively studied. In this review, we examine the role of DNA methylation in RCC disease etiology and progression, the preclinical use of DNA methylation alterations as diagnostic, prognostic and predictive biomarkers, and the potential for DNA methylation-directed therapies.

相关
加载中…
  • Diagnostic DNA Methylation Markers for Renal Cell Carcinoma: A Systematic Review
    Lommen K.; Vaes N.; Aarts M. J.; van Roermund J. G.; Schouten L. J.; Melotte V.; Tjan-Heijnen V. C.; van Engeland M.; Smits K. M.11th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland, 2018-06-19 To 2018-06-22.
  • DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
    Emma Andersson Evelönn; Mattias Landfors; Zahra Haider; Linda Köhn; Börje Ljungberg; Göran Roos; Sofie Degerman2019.
  • Molecular Characterization, Tumor Microenvironment Association, and Drug Susceptibility of DNA Methylation-Driven Genes in Renal Cell Carcinoma
    Wang, Jinpeng; Zhang, Wei; Hou, Wenbin; Zhao, Enyang*; Li, Xuedong*Frontiers in Cell and Developmental Biology, 2022, 10: 837919.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Diagnosis and Therapy
发表日期
2018-05-18
DOI
10.1007/s40291-018-0337-9
语言
ENGLISH
期刊等级
Q2
成果收录
PUBMED

作者

  • L

    Lasseigne Brittany N (通讯) (第一作者)

  • B

    Brooks James D

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417